Browse 1,492 gastrointestinal clinical trials enrolling across the United States and Canada. 173 people applied to gastrointestinal studies last month. Search by city or state to find one near you.
Filter
1
Filter results
Results: 1,492
Active & Responsive
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
for
Colorectal Cancer
Location: Toms River NJ, Edison NJ, East Brunswick NJ, Monroe NJ,
Sponsor: Exelixis
Sex: All
Age: 18+
Code: NCT07750158
Phase 3, Recruiting
Active & Responsive
Microbiome-targeted Diet Therapy in Ulcerative Colitis
for
Ulcerative Colitis
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT07520461
Recruiting
Active & Responsive
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
for
Locally Advanced Ampulla of Vater Carcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT07780838
Phase 2, Recruiting
Active & Responsive
Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]
for
Colorectal Cancer, Regorafenib, High Risk Patients
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07071961
Phase 2, Recruiting
Active & Responsive
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Get alerts for new trials in your area by subscribing now
Active & Responsive
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
for
Metastatic Colorectal Adenocarcinoma,
Location: Baltimore MD, Washington D.C. DC, Atlanta GA, Aurora CO